Trifluoroacetic acid → Morpholine-2-carboxylic acid [6-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)pyridin-2-yl]amide
Reaction equation
C(O)(C(F)(F)F)=O.C(OC([N:15]1[CH2:20][CH2:19][O:18][CH:17]([C:21](=[O:43])[NH:22][C:23]2[CH:28]=[CH:27][CH:26]=[C:25]([C:29]3[CH:38]=[CH:37][C:36]4[C:35]([CH3:40])([CH3:39])[CH2:34][CH2:33][C:32]([CH3:42])([CH3:41])[C:31]=4[CH:30]=3)[N:24]=2)[CH2:16]1)=O)(C)(C)C>C(Cl)Cl>[CH3:39][C:35]1([CH3:40])[CH2:34][CH2:33][C:32]([CH3:41])([CH3:42])[C:31]2[CH:30]=[C:29]([C:25]3[N:24]=[C:23]([NH:22][C:21]([CH:17]4[O:18][CH2:19][CH2:20][NH:15][CH2:16]4)=[O:43])[CH:28]=[CH:27][CH:26]=3)[CH:38]=[CH:37][C:36]1=2Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The protecting group is cleaved off as already described using TFA in DCM starting from 92 mg (0.19 mmol) of 2-[6-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)pyridin-2-ylcarbamoyl]morpholine-4-carboxylic acid tert-butyl ester from step b. The product is purified by means of preparative HPLC and is in the form of the TFA salt.
Workup
- customThe product is purified by means of preparative HPLC
Sources & evidence
- ORD record
- ord-c9637eb2815a459eaea54e75fd37a05e
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08907098B2
Reaction notes
Loading…